This Tweet is currently unavailable. It might be loading or has been removed.
BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
。快连下载安装对此有专业解读
Read the full story at The Verge.
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
。关于这个话题，同城约会提供了深入分析
FirstFT: the day's biggest stories，推荐阅读WPS下载最新地址获取更多信息
But is there a limit to how connected crowds really want to be?